An unnamed strategic investor has contributed to the Johnson & Johnson-backed medical device producer's latest round.

The mobile software provider was among the participants in a $29.2m round for the cardiovascular disease and stroke diagnostics technology developer.

Leaps by Bayer co-led a $55m series A round for cancer immunotherapy developer Triumvira Immunologics, which was co-founded by McMaster's Jonathan Bramson.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Leaps by Bayer co-led a $55m series A round for cancer immunotherapy developer Triumvira Immunologics and is getting two board seats.

The medical research services provider received nearly $43.5m in a round that came seven months after an investment from China Life Private Equity.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Intel Capital came in as a new investor for a round that pushed the genome engineering technology provider's overall funding to $260m.

NetScientific and EMV Capital have completed their merger to assemble a portfolio of 15 companies in healthcare, energy and industrial tech.

The TTO reported decreased spinout generation, licensing revenue and funding however marked a notable exit in the sale of Tissue Analytics.